Centre signs deal with Biological-E for 300 million COVID vaccine doses
The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months ...
The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months ...
India’s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.